APA (7th ed.) Citation

Suminaga, K., Nomizo, T., Yoshida, H., & Ozasa, H. The impact of PD-L1 polymorphisms on the efficacy of immune checkpoint inhibitors depends on the tumor proportion score: A retrospective study. Springer.

Chicago Style (17th ed.) Citation

Suminaga, Keiichiro, Takashi Nomizo, Hironori Yoshida, and Hiroaki Ozasa. The Impact of PD-L1 Polymorphisms on the Efficacy of Immune Checkpoint Inhibitors Depends on the Tumor Proportion Score: A Retrospective Study. Springer.

MLA (9th ed.) Citation

Suminaga, Keiichiro, et al. The Impact of PD-L1 Polymorphisms on the Efficacy of Immune Checkpoint Inhibitors Depends on the Tumor Proportion Score: A Retrospective Study. Springer.